Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 92%
filed 2026-08-20
Item 5.02
The filing discloses the appointment of François Vachon as Chief Executive Officer (effective August 13, 2026) and as a Board member (effective August 18, 2026), along with the appointment of Kurtis W. Winn to additional officer roles. While Lin Li's resignation as CEO and director is also disclosed, the principal action centers on the appointment of a new CEO with detailed compensation terms ($7,000–$10,000 monthly base salary, one-year term) and extensive responsibilities for governance, compliance, manufacturing oversight, and capital raising. This is a material executive appointment affecting the registrant's leadership structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-08-20
Item 8.01
Pitney Bowes announced the commencement of cash tender offers to purchase up to $50 million aggregate principal amount of its outstanding 6.70% Notes due 2043 and 5.250% Medium-Term Notes due 2037. While this is technically a debt repurchase rather than issuance, it represents a material modification of the company's direct financial obligations and capital structure. The tender offer is a significant financial event affecting the company's debt portfolio and liquidity position, warranting disclosure under Item 8.01 as a material event.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-08-20
Item 8.01
Standard Nuclear announced execution of a binding fuel supply agreement with Radiant Industries for multi-metric-ton TRISO fuel deliveries through 2031. This is a material commercial contract securing multi-year customer demand for the company's core product, but it does not fit the specific categories of M&A activity, debt issuance, or other named financial/operational events. The agreement represents a significant operational and strategic milestone for an early-stage advanced nuclear fuel producer, making it a material operational event.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 98%
filed 2026-08-20
Item 3.01
BullFrog AI received notice from Nasdaq on August 18, 2026, that while it has not regained compliance with the Minimum Bid Price Requirement (closing bid price below $1.00 per share), it has been granted a second 180-calendar-day compliance period until February 8, 2027. The filing explicitly states that if the Company does not regain compliance by that date, "the Company's listed securities will be subject to delisting." This is a direct delisting risk disclosure under Item 3.01, materially affecting investor assessment of the registrant's continued listing status.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-20
EX-99.1
This press release announces a multi-year global partnership between Prenetics' IM8 brand and actress Lily Collins as a Global Ambassador and shareholder. While the disclosure includes forward-looking revenue guidance ($220+ million for FY 2026, $400+ million for FY 2027), the primary event is the strategic partnership and brand ambassador arrangement—a material operational and marketing development for the company's growth strategy. The guidance is secondary context supporting the partnership's significance, not the principal disclosure. This is a strategic business partnership that would affect investor assessment of the company's market reach and growth trajectory.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-20
Item 5.02
The filing discloses the appointment of Michael D. Stein to the Board of Governors on August 19, 2026, to fill a vacancy. The principal action is a person taking a governance role, with assignment to three board committees (risk management, audit, and fixed assets). This is a clear executive appointment under Item 5.02 and is material to investors as board composition affects governance and oversight.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-20
Item 3.02
Rise Companies Corp. qualified 4,275,000 shares of Class B Common Stock for sale in a continuous offering under Regulation A (Rule 251(d)(3)), with an expected offering period through September 23, 2028. This unregistered equity issuance will dilute existing shareholders and raise capital for the company.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 75%
filed 2026-08-20
EX-99.1
The exhibit announces the appointment of Finn Age Hänsel as President, Rest of World & Chief Strategy Officer and Adrian Frenzel as Global Chief Operating Officer. While the document also discusses the amended earnout agreement and integration strategy, the principal disclosed actions are executive appointments to senior leadership roles. These appointments are material to investors as they reflect significant organizational restructuring and leadership changes following the Sanity acquisition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 97%
filed 2026-08-20
Item 2.03
Corebridge Financial issued $750 million in aggregate principal amount of 5.900% Senior Notes due 2036 pursuant to an Underwriting Agreement dated August 17, 2026 and a Ninth Supplemental Indenture executed on August 20, 2026. The company intends to use the proceeds to refinance existing debt obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 88%
filed 2026-08-20
Item 2.03
Suja Life entered into an Amended and Restated Credit Agreement with JPMorgan Chase Bank that modifies its existing credit facility originally dated August 23, 2021. The amendment reduces the borrowing spread and lowers the Company's cost of capital, with the new interest rate terms set at Term SOFR plus 1.75%-2.25% based on leverage ratio, resulting in expected 2026 total interest expense improvement to $18.0 million.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 1.01
Blue Owl Technology Finance Corp. entered into a $250 million revolving credit facility with Natixis as administrative agent on August 14, 2026, with a 10-year maturity and interest at SOFR plus 2.25%, to finance asset origination and acquisition.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 97%
filed 2026-08-20
Item 2.03
Blue Owl Technology Finance Corp. issued an additional $400 million aggregate principal amount of 6.500% notes due 2029 on August 20, 2026, bringing total outstanding notes to $900 million, with net proceeds to be used to pay down existing senior secured revolving credit facility indebtedness.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-08-20
Item 1.01
Senti Holdings, a wholly owned subsidiary, issued and sold $4.0 million in aggregate principal amount of Senior Secured Convertible Notes to Celadon Partners SPV 24 pursuant to a Securities Purchase Agreement dated April 27, 2026, creating a new direct financial obligation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-08-20
Item 2.03
An entity affiliated with Celadon would merge with and into Senti Holdings, with contingent value rights worth up to $60 million tied to regulatory and sales milestones for SENTI-202, constituting a material acquisition and change of control transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-20
Item 1.01
James Hardie entered into a definitive Share Purchase Agreement to sell its European fibre gypsum and cement-bonded products business (Fermacell) to Holcim for €840 million (~$980 million USD), with expected closure in H1 2027. The transaction includes closure of the European fiber cement business and is expected to materially reshape the company's portfolio, accelerate deleveraging, and fund a $250 million share repurchase program.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-20
Item 5.07
This is a clear disclosure of shareholder vote results from RCI Hospitality Holdings' Annual Meeting of Stockholders held on August 20, 2026. The filing reports voting outcomes on three matters: election of six directors (Item 1), ratification of CBIZ CPAs P.C. as independent auditor (Item 2), and approval of a non-binding advisory resolution on executive compensation (Item 3), with detailed vote tallies for each. This is a quintessential Item 5.07 disclosure and material to investors as it reflects governance decisions and shareholder approval of key corporate matters.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-20
Item 8.01
The filing discloses a declaration of a quarterly cash dividend of $0.15 per share payable on September 17, 2026, to stockholders of record as of September 3, 2026. This is a routine but material dividend distribution to shareholders, clearly fitting the dividend_distribution event type. The press release confirms the Board's declaration and the CEO's comment about continuing the quarterly dividend reinforces this is a regular capital distribution to shareholders.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-08-20
Item 5.02
Ana Dutra was elected as an independent director of Tredegar Corporation and appointed to the Board's Executive Compensation Committee, effective August 17, 2026. The appointment strengthens the Board's governance and oversight capabilities.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-08-20
Methanex announced that Natgasoline LLC (50% joint venture) has priced a $290.95 million issuance of tax-exempt bonds with a 4.75% coupon, maturing in 2046, to refinance existing 2018 municipal bonds. This constitutes creation of a new direct financial obligation for the joint venture in which Methanex holds a material equity interest, and the refinancing activity is disclosed as a material corporate event affecting the entity's capital structure and cash flow flexibility.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-20
EX-99.1
This press release announces positive preliminary Phase 1 clinical trial data for ACI-19764, an NLRP3 inhibitor. The disclosure reports safety, tolerability, pharmacokinetics, and pharmacodynamic results from a first-in-human study, including confirmed brain penetration and dose-dependent IL-1beta inhibition. While this is a clinical development milestone rather than a discrete event like M&A or executive change, it represents material operational progress for a clinical-stage biopharmaceutical company that would affect a reasonable investor's assessment of the company's pipeline and therapeutic potential.
View raw filing on EDGAR →
6-K
Exec Compensation
confidence 92%
filed 2026-08-20
HSBC granted conditional awards to employees and former employees for 286,184 ordinary shares under the HSBC Share Plan 2011 on 19 August 2026. The announcement discloses compensatory arrangements including vesting schedules (3–5 years depending on employee category), retention periods, clawback provisions, and performance targets—all hallmarks of executive and employee equity compensation arrangements subject to Item 5.02(e) disclosure requirements.
View raw filing on EDGAR →
6-K
M&A activity
confidence 95%
filed 2026-08-20
EX-99.1
Vox Royalty has entered into a binding Royalty Sale and Purchase Agreement to acquire two Australian royalty interests (Kalman and Sylvania) for total cash consideration of up to A$3.4 million. This is a material acquisition of assets that expands the company's royalty portfolio and represents a discrete M&A transaction subject to customary conditions precedent, consistent with Item 1.01 (Material Agreements) or Item 2.01 (Completion of Acquisition or Disposition of Assets) disclosure requirements.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of New York. Schedule A lists specific debt securities with trade dates in August 2026, settlement dates, maturity dates, and principal amounts totaling approximately $2.1 billion. This is a classic debt issuance disclosure under Item 2.03, material to investors assessing the Bank's capital structure and funding activities.
View raw filing on EDGAR →
8-K
Governance Other
confidence 72%
filed 2026-08-20
Item 1.01
Hertz entered into an amended and restated voting agreement with CK Amarillo LP on August 20, 2026, in connection with settlement of litigation. The agreement imposes voting restrictions on CK Amarillo's Excess Voting Securities (those exceeding 45% of voting power) and adds a sale-of-control provision requiring CK Amarillo to deliver proceeds to common shareholders if it sells 50%+ of shares above market price. While this is a material definitive agreement affecting shareholder voting rights and control dynamics, it does not fit the specific governance categories (exec_departure, exec_appointment, exec_compensation, shareholder_vote_results) and is best classified as a governance matter outside those named types.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-20
Item 3.02
The filing discloses unregistered sales of equity securities totaling approximately $33.9 million across two share classes (Class C and Class L) sold on July 1 and August 1, 2026. The sales were exempt from registration under Section 4(a)(2), Regulation S, and Regulation D—classic private placement mechanics. This represents a material dilutive issuance that would affect investor assessment of ownership and capital structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 94%
filed 2026-08-20
Item 2.03
DarkPulse issued five unsecured promissory notes totaling $2.78 million on August 8, 2026, bearing 8% fixed interest and maturing by October 1, 2026, creating a new direct financial obligation that materially affects the company's capital structure and liquidity position.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-20
Item 8.01
DarkPulse submitted a bid to acquire substantially all assets of Aero Precision and Ballistic Advantage for approximately $35.0 million in a receivership proceeding, depositing $2.77 million and securing a $40.0 million financing commitment, though no definitive agreement has yet been executed by the receiver.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-08-20
Item 7.01
The filing discloses that Cable & Wireless Communications Limited (C&W), a wholly-owned subsidiary of Liberty Latin America, made available its financial report for the quarter ended June 30, 2026. This constitutes a quarterly earnings release for a material operating subsidiary. Although disclosed under Item 7.01 (Regulation FD Disclosures) rather than Item 2.02, the substance is the public disclosure of quarterly financial results, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 85%
filed 2026-08-20
Item 7.01
Liberty Latin America disclosed the financial report of its wholly-owned subsidiary Liberty PR for Q2 2026 (quarter ended June 30, 2026) made available on the company's investor relations website. This constitutes a quarterly earnings disclosure, which is material to investors assessing the registrant's financial performance and condition, even though it is furnished under Item 7.01 (Regulation FD Disclosures) rather than the more typical Item 2.02.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 88%
filed 2026-08-20
Item 3.02
On August 19, 2026, Sadot Group Inc. issued 33,968 common shares at a below-market price to settle an assigned debenture with an existing debt holder, relying on the Section 3(a)(9) exemption. The debt-for-equity conversion resulted in dilution to existing shareholders and triggered anti-dilution adjustments in other debt instruments.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-20
Item 1.01
VisionWave entered into a Strategic Cooperation Agreement with Foresight Automotive to jointly develop and commercialize defense and military-oriented autonomous solutions, integrating Foresight's perception technology with VisionWave's VARAN UGV platform. While this is a material strategic partnership affecting the company's business development and commercialization prospects, it does not constitute a traditional M&A transaction (no acquisition, merger, or change of control), nor does it fit other specific event categories. The agreement is non-exclusive, contains no minimum purchase obligations, requires no upfront fees, and contemplates future definitive agreements for detailed commercial terms, making it a strategic operational partnership rather than a completed material acquisition or disposition.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-20
WF International entered into a Share Purchase Agreement on August 19, 2026, to sell and issue 111,333 ordinary shares at $1.50 per share in a registered direct offering, expected to close August 21, 2026. The offering is registered under Form F-3 and will raise approximately $166,999.50 in gross proceeds. This is a registered direct offering of equity securities that dilutes existing shareholders and is material to investor assessment of capital structure and ownership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-20
Item 2.02
This is a classic earnings release disclosure under Item 2.02. The company issued a press release on August 20, 2026 announcing financial results for the second quarter ended June 30, 2026, reporting a 64% improvement in loss from continuing operations ($4 million vs. $11 million year-over-year). The press release is furnished as Exhibit 99.1 and includes both financial results and strategic updates. This is material to investors as it discloses quarterly operating performance and significant cost-reduction achievements.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-20
EX-99.1
This press release announces Ruanyun Edai's long-term strategic expansion of its YeeZo AIGC platform to up to 200 universities over 36 months, with an illustrative revenue potential of ~$405 million. The disclosure outlines a phased deployment strategy, describes the initial university technical-services agreement for ~350 users, and articulates four connected outcomes (university capability, student capability, industry capacity, and economic formation). While the company explicitly disclaims this as financial guidance and emphasizes contingencies, the announcement represents a material strategic initiative and operational milestone that would affect a reasonable investor's assessment of the company's growth trajectory and business direction. The event does not fit neatly into earnings, M&A, workforce, or other discrete categories, making operational_other the appropriate classification.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-20
Item 3.02
Monroe Capital issued 1,664,638 shares of common stock at $9.77 per share for an aggregate offering price of $16.3 million pursuant to subscription agreements, exempt from registration under Section 4(a)(2) and Regulation D/S.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-20
Item 8.01
The board declared a dividend distribution of $0.068 per share to stockholders of record as of August 21, 2026, payable on or about August 27, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-08-20
Item 1.01
Charlotte's Web Holdings' subsidiary CW entered into a Convertible Promissory Note with DeFloria, Inc. with an aggregate principal amount of $1,582,500, bearing interest at 11.25% per annum (initially) and subject to conversion upon qualified financing or at maturity. This is a creation of a new direct financial obligation under Item 1.01, fitting the debt_issuance category. The material terms—principal amount, interest rate, conversion features, and Events of Default—are typical of convertible debt disclosures and would affect a reasonable investor's assessment of the company's capital structure and obligations.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-20
Item 2.02
This is a clear earnings release disclosing Hovnanian Enterprises' preliminary financial results for fiscal Q3 2026 (ended July 31, 2026). The filing explicitly states "Hovnanian Enterprises, Inc. (the 'Company') issued a press release announcing its preliminary financial results for the fiscal third quarter ended July 31, 2026" and includes detailed results on revenues ($705.7M), gross margins (11.8%), net loss ($4.5M), and forward guidance for Q4. The press release is attached as Exhibit 99.1 and contains comprehensive financial metrics and management commentary typical of quarterly earnings disclosures under Item 2.02.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-08-20
EX-99.1
SU Group announced it has "regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2)" and is "in compliance with the Nasdaq Capital Market's listing requirements." This disclosure directly addresses a delisting risk — the company was previously non-compliant with Nasdaq's minimum bid price rule and has now resolved that deficiency. The announcement confirms the Class A Ordinary Shares will "continue to be listed and traded on The Nasdaq Stock Market," resolving an imminent delisting threat.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 1.01
Carvana Receivables Depositor LLC entered into an underwriting agreement on August 18, 2026 for the issuance of approximately $1.55 billion in asset-backed notes across multiple classes by Carvana Auto Receivables Trust 2026-P3, representing a material creation of direct financial obligations through a structured securitization.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-08-20
Item 8.01
The filing discloses the public issuance of multiple classes of Asset Backed Notes (Class A-1 through Class D) by Carvana Auto Receivables Trust 2026-P3, with specified principal amounts documented in a prospectus dated August 18, 2026. This constitutes creation of new direct financial obligations and is a material debt issuance event requiring 8-K disclosure under Item 2.03 (or Item 8.01 as here). The attachment of legality and tax opinions confirms the formal completion of the debt offering.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
Dynatrace issued $1.4375 billion aggregate principal amount of 0.00% Exchangeable Senior Notes due 2031 in a private placement to qualified institutional buyers, with settlement on August 20, 2026. The notes are senior, unsecured obligations of Dynatrace LLC guaranteed by Dynatrace, with an initial exchange rate of 15.5585 shares per $1,000 principal amount and approximately $1.227 billion in net proceeds.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-20
Item 3.02
In connection with the exchangeable notes offering, Dynatrace's subsidiary issued warrants to purchase up to 44.7 million shares of common stock, and up to 30.2 million shares of common stock are potentially issuable upon exchange of the notes. The warrant and exchange transactions were issued in a private placement under Rule 144A and Section 4(a)(2), creating potential dilution to existing shareholders.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-20
EX-99.1
This exhibit is a press release announcing BioNTech's presentation of clinical trial data at the WCLC 2026 conference, highlighting progress in its lung cancer pipeline including novel-novel combination trials (pumitamig + elfetabart drozuntecan), updated overall survival data for gotistobart, and mRNA-based approaches across 16 ongoing trials including five Phase 3 studies. While the disclosure concerns clinical development progress rather than a discrete event like an approval, acquisition, or financial result, it represents material operational and strategic progress in the company's core oncology development program that would affect a reasonable investor's assessment of pipeline momentum and competitive positioning.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-20
Item 3.02
Blackstone Private Credit Fund completed an unregistered private placement of 1,339,715 Class I common shares for $31.7 million, conducted pursuant to Section 4(a)(2) and Regulation S exemptions.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-20
Item 7.01
The Fund declared regular distributions to shareholders across Class I, S, and D share classes, with specified per-share amounts, record dates, and payment dates.
View raw filing on EDGAR →
8-K
Financial Other
confidence 65%
filed 2026-08-20
Item 8.01
The Fund disclosed its NAV per share ($23.64), aggregate NAV ($43.0 billion), portfolio fair value ($77.2 billion), debt outstanding ($37.1 billion), leverage ratio (0.81x), and ongoing public and private share offering status ($57.1 billion issued to date against a $45.0 billion authorization).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-08-20
Item 1.01
Energy Vault entered into a senior secured term loan credit agreement for approximately $137.5 million on August 14, 2026, with interest rates of 6.75%-7.50% SOFR or 5.75%-6.50% ABR, maturing January 2, 2028, and secured by substantially all assets of the borrower subsidiaries.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-08-20
Item 5.07
This is a clear disclosure of shareholder vote results from NeOnc Technologies' 2026 annual meeting held on August 14, 2026. The filing reports final voting tallies on four proposals: election of two Class I directors (Victoria Medvec and Steven L. Giannotta), amendment of the 2023 Equity Incentive Plan, ratification of CBIZ CPAs P.C. as independent auditor, and adjournment authority. All proposals passed with substantial majorities. This is a material governance event affecting investor understanding of board composition and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-20
The filing discloses results of an extraordinary general meeting held on August 19, 2026, where RF Acquisition Corp II shareholders voted on six proposals, including approval of a business combination with Nanyang Biologics Pte. Ltd. Item 5.07 reports detailed voting results for each proposal (Business Combination Proposal, Merger Proposal, Advisory Governance Proposals, Nasdaq Proposal, Incentive Plan Proposal, and Adjournment Proposal), with the Business Combination Proposal receiving 6,765,584 votes in favor and 440,604 against. This is a material shareholder vote on a significant M&A transaction.
View raw filing on EDGAR →